CNS Pharmaceuticals, Inc.
CNSPNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CNSP. That does not mean none is planned.
Get an email about CNSP's next catalysts
Track CNS Pharmaceuticals (CNSP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Berubicin | Phase 2 | Glioblastoma Multiforme, Adult | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in CNS Pharmaceuticals, Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in CNS Pharmaceuticals, Inc.'s (CNSP) pipeline across Phase 2. Its lead program is Berubicin (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CNS Pharmaceuticals, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for CNS Pharmaceuticals, Inc. (CNSP) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CNSP biotech catalysts?β
Add CNSP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CNS Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
